Pharmaniaga Berhad, established in 1994, stands as one of Malaysia's leading integrated pharmaceutical groups. The company embodies a comprehensive approach to the pharmaceutical industry, participating in various segments including research and development, manufacturing of generic drugs, and production of over-the-counter medicines. Pharmaniaga also excels in logistics and distribution, ensuring that its products reach customers efficiently.

With a strong commitment to innovation, Pharmaniaga made history in 2021 as the first Malaysian company to manufacture and fill a human vaccine. The company continues to broaden its horizons by exploring opportunities for strategic international expansion. Its extensive portfolio includes pharmaceuticals, medical equipment, consumables, and devices, underscoring its versatile offerings in healthcare.

Pharmaniaga emphasizes sustainable business practices that positively impact patients, employees, and communities, reinforcing its belief that corporate responsibility is key to enduring success. The company remains dedicated to delivering high-quality healthcare solutions while navigating towards enhanced financial stability and growth.